ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,117.10
1.04%
Dow Jones
38,633.48
1.07%
US Dollar vs MXN
17.012
0.23%
Brent Oil
83.255
-0.45%
Bitcoin
61,605.66
4.20%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Inovio Pharmaceuticals Inc New (INO)

  7. Inovio Pharmaceuticals Inc New (INO) Noticias

INO

Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals Inc New
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:INO
FechaHoraFuenteTítuloSímboloCompañía
01/05/202407:00PR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
29/04/202407:00PR Newswire (US)INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024NASDAQ:INOInovio Pharmaceuticals Inc New
29/04/202407:00PR Newswire (US)INOVIO to Participate in Upcoming Investor Conferences in MayNASDAQ:INOInovio Pharmaceuticals Inc New
15/04/202417:39PR Newswire (US)INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsNASDAQ:INOInovio Pharmaceuticals Inc New
26/03/202417:28PR Newswire (US)INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn MedicineNASDAQ:INOInovio Pharmaceuticals Inc New
06/03/202415:05PR Newswire (US)INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:INOInovio Pharmaceuticals Inc New
06/03/202406:00PR Newswire (US)Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:INOInovio Pharmaceuticals Inc New
06/03/202405:02IH Market NewsU.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices ClimbNASDAQ:INOInovio Pharmaceuticals Inc New
21/02/202407:00PR Newswire (US)INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024NASDAQ:INOInovio Pharmaceuticals Inc New
07/02/202410:46PR Newswire (US)INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:INOInovio Pharmaceuticals Inc New
02/02/202407:00PR Newswire (US)INOVIO Reports Inducement Grant Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
31/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INOInovio Pharmaceuticals Inc New
26/01/202415:01Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:INOInovio Pharmaceuticals Inc New
25/01/202415:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
23/01/202407:00PR Newswire (US)INOVIO Announces Effective Date of 1-for-12 Reverse Stock SplitNASDAQ:INOInovio Pharmaceuticals Inc New
22/01/202407:00PR Newswire (US)INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion LeaderNASDAQ:INOInovio Pharmaceuticals Inc New
04/01/202407:00PR Newswire (US)INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)NASDAQ:INOInovio Pharmaceuticals Inc New
03/01/202407:00PR Newswire (US)INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval ProgramNASDAQ:INOInovio Pharmaceuticals Inc New
28/11/202315:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INOInovio Pharmaceuticals Inc New
17/11/202315:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:INOInovio Pharmaceuticals Inc New
09/11/202315:35Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INOInovio Pharmaceuticals Inc New
09/11/202315:05PR Newswire (US)INOVIO Reports Third Quarter 2023 Financial Results and Operational HighlightsNASDAQ:INOInovio Pharmaceuticals Inc New
09/11/202315:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INOInovio Pharmaceuticals Inc New
26/10/202307:00PR Newswire (US)INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023NASDAQ:INOInovio Pharmaceuticals Inc New
10/10/202309:51Dow Jones NewsInovio Shares Rise 8% After FDA Feedback for INO-3107NASDAQ:INOInovio Pharmaceuticals Inc New
10/10/202307:00PR Newswire (US)INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval ProgramNASDAQ:INOInovio Pharmaceuticals Inc New
27/09/202318:39PR Newswire (US)Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 MillionNASDAQ:INOInovio Pharmaceuticals Inc New
07/09/202307:00PR Newswire (US)INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory PapillomatosisNASDAQ:INOInovio Pharmaceuticals Inc New
29/08/202307:00PR Newswire (US)INOVIO to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:INOInovio Pharmaceuticals Inc New
09/08/202315:05PR Newswire (US)INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic UpdateNASDAQ:INOInovio Pharmaceuticals Inc New
 Showing the most relevant articles for your search:NASDAQ:INO

Su Consulta Reciente

USOTC
RHHBY
Roche (QX)
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
AMZN
Amazon.com
NYSE
JPM
JP Morgan Chase
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
NYSE
DIS
Walt Disney
SPI
SP500
S&P 500
NYSE
XOM
Exxon Mobil
USI
USTECH100
US Tech 100
NYSE
MRK
Merck
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BASFY
BASF (QX)
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados